XML 52 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 28, 2014
Jun. 29, 2013
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations $ (25,427) $ 5,738
Net cash (used in) provided by operating activities of discontinued operations (1,687) 3,608
Net cash (used in) provided by operating activities (27,114) 9,346
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired 0 (5,145)
Capital expenditures (16,777) (15,615)
Purchase of investment (2,000) (1,650)
Proceeds from insurance claim 0 3,036
Proceeds from sale of property, plant and equipment 320 7,561
Net cash used in investing activities of continuing operations (18,457) (11,813)
Net cash provided by (used in) investing activities of discontinued operations 2,196 (115)
Net cash used in investing activities (16,261) (11,928)
Cash flows from financing activities:    
Proceeds from issuance of 6.000% senior secured priority notes due 2019 540,000 0
Proceeds from issuance of 8.500% junior secured priority notes due 2022 250,000 0
Repayment of 7.875% senior subordinated notes 0 (67,848)
Repayment of Term Loan B due 2016 0 (389,105)
Payment of financing-related costs and expenses and debt issuance discounts (35,017) (13,884)
Repayments of other long-term debt (2,967) (2,413)
Purchase and retirement of common stock upon vesting of RSUs (562) (363)
Repayments under Revolving Credit Facility, net 0 (18,000)
Proceeds from issuance of 15% Unsecured Term Loan due 2017 0 50,000
Repayment of 15% Unsecured Term Loan due 2017 (10,000) (15,000)
Proceeds from issuance of Term Loan Facility due 2017 0 360,000
Repayment of Term Loan Facility due 2017 (329,100) 0
Repayment of 8.875% senior second lien notes due 2018 (400,000) 0
Borrowings under ABL Facility due 2017 287,900 266,700
Repayments under ABL Facility due 2017 (258,900) (163,900)
Intercompany advances 0 0
Net cash provided by financing activities 41,354 6,187
Effect of exchange rate changes on cash and cash equivalents 20 161
Net (decrease) increase in cash and cash equivalents (2,001) 3,766
Cash and cash equivalents at beginning of period 11,329 8,110
Cash and cash equivalents at end of period 9,328 11,876
Parent Company [Member]
   
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 1,672 1,977
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash (used in) provided by operating activities 1,672 1,977
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures 0 0
Purchase of investment 0 0
Proceeds from insurance claim   0
Proceeds from sale of property, plant and equipment 0 0
Net cash used in investing activities of continuing operations 0 0
Net cash provided by (used in) investing activities of discontinued operations 0 0
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 6.000% senior secured priority notes due 2019 0  
Proceeds from issuance of 8.500% junior secured priority notes due 2022 0  
Repayment of 7.875% senior subordinated notes   0
Repayment of Term Loan B due 2016   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Repayments of other long-term debt 0 0
Purchase and retirement of common stock upon vesting of RSUs (562) (363)
Repayments under Revolving Credit Facility, net   0
Proceeds from issuance of 15% Unsecured Term Loan due 2017   0
Repayment of 15% Unsecured Term Loan due 2017 0 0
Proceeds from issuance of Term Loan Facility due 2017   0
Repayment of Term Loan Facility due 2017 0  
Repayment of 8.875% senior second lien notes due 2018 0  
Borrowings under ABL Facility due 2017 0 0
Repayments under ABL Facility due 2017 0 0
Intercompany advances (1,110) (1,614)
Net cash provided by financing activities (1,672) (1,977)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net (decrease) increase in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Subsidiary Issuer [Member]
   
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations (79,382) (56,895)
Net cash (used in) provided by operating activities of discontinued operations (730) 2,486
Net cash (used in) provided by operating activities (80,112) (54,409)
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   (5,145)
Capital expenditures (8,424) (8,900)
Purchase of investment (2,000) (1,650)
Proceeds from insurance claim   0
Proceeds from sale of property, plant and equipment 166 222
Net cash used in investing activities of continuing operations (10,258) (15,473)
Net cash provided by (used in) investing activities of discontinued operations 1,033 (115)
Net cash used in investing activities (9,225) (15,588)
Cash flows from financing activities:    
Proceeds from issuance of 6.000% senior secured priority notes due 2019 540,000  
Proceeds from issuance of 8.500% junior secured priority notes due 2022 250,000  
Repayment of 7.875% senior subordinated notes   (67,848)
Repayment of Term Loan B due 2016   (389,105)
Payment of financing-related costs and expenses and debt issuance discounts (35,017) (13,884)
Repayments of other long-term debt (1,500) 0
Purchase and retirement of common stock upon vesting of RSUs 0 0
Repayments under Revolving Credit Facility, net   (18,000)
Proceeds from issuance of 15% Unsecured Term Loan due 2017   50,000
Repayment of 15% Unsecured Term Loan due 2017 (10,000) (15,000)
Proceeds from issuance of Term Loan Facility due 2017   360,000
Repayment of Term Loan Facility due 2017 (329,100)  
Repayment of 8.875% senior second lien notes due 2018 (400,000)  
Borrowings under ABL Facility due 2017 287,900 266,700
Repayments under ABL Facility due 2017 (258,900) (163,900)
Intercompany advances 43,802 65,307
Net cash provided by financing activities 87,185 74,270
Effect of exchange rate changes on cash and cash equivalents 0 0
Net (decrease) increase in cash and cash equivalents (2,152) 4,273
Cash and cash equivalents at beginning of period 9,504 5,763
Cash and cash equivalents at end of period 7,352 10,036
Guarantor Subsidiaries [Member]
   
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 54,411 61,867
Net cash (used in) provided by operating activities of discontinued operations (957) 1,122
Net cash (used in) provided by operating activities 53,454 62,989
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures (8,306) (6,654)
Purchase of investment 0 0
Proceeds from insurance claim   3,036
Proceeds from sale of property, plant and equipment 154 7,339
Net cash used in investing activities of continuing operations (8,152) 3,721
Net cash provided by (used in) investing activities of discontinued operations 1,163 0
Net cash used in investing activities (6,989) 3,721
Cash flows from financing activities:    
Proceeds from issuance of 6.000% senior secured priority notes due 2019 0  
Proceeds from issuance of 8.500% junior secured priority notes due 2022 0  
Repayment of 7.875% senior subordinated notes   0
Repayment of Term Loan B due 2016   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Repayments of other long-term debt (1,467) (2,413)
Purchase and retirement of common stock upon vesting of RSUs 0 0
Repayments under Revolving Credit Facility, net   0
Proceeds from issuance of 15% Unsecured Term Loan due 2017   0
Repayment of 15% Unsecured Term Loan due 2017 0 0
Proceeds from issuance of Term Loan Facility due 2017   0
Repayment of Term Loan Facility due 2017 0  
Repayment of 8.875% senior second lien notes due 2018 0  
Borrowings under ABL Facility due 2017 0 0
Repayments under ABL Facility due 2017 0 0
Intercompany advances (44,766) (64,526)
Net cash provided by financing activities (46,233) (66,939)
Effect of exchange rate changes on cash and cash equivalents 4 7
Net (decrease) increase in cash and cash equivalents 236 (222)
Cash and cash equivalents at beginning of period 0 286
Cash and cash equivalents at end of period 236 64
Non-Guarantor Subsidiaries [Member]
   
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations (2,128) (1,211)
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash (used in) provided by operating activities (2,128) (1,211)
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures (47) (61)
Purchase of investment 0 0
Proceeds from insurance claim   0
Proceeds from sale of property, plant and equipment 0 0
Net cash used in investing activities of continuing operations (47) (61)
Net cash provided by (used in) investing activities of discontinued operations 0 0
Net cash used in investing activities (47) (61)
Cash flows from financing activities:    
Proceeds from issuance of 6.000% senior secured priority notes due 2019 0  
Proceeds from issuance of 8.500% junior secured priority notes due 2022 0  
Repayment of 7.875% senior subordinated notes   0
Repayment of Term Loan B due 2016   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Repayments of other long-term debt 0 0
Purchase and retirement of common stock upon vesting of RSUs 0 0
Repayments under Revolving Credit Facility, net   0
Proceeds from issuance of 15% Unsecured Term Loan due 2017   0
Repayment of 15% Unsecured Term Loan due 2017 0 0
Proceeds from issuance of Term Loan Facility due 2017   0
Repayment of Term Loan Facility due 2017 0  
Repayment of 8.875% senior second lien notes due 2018 0  
Borrowings under ABL Facility due 2017 0 0
Repayments under ABL Facility due 2017 0 0
Intercompany advances 2,074 833
Net cash provided by financing activities 2,074 833
Effect of exchange rate changes on cash and cash equivalents 16 154
Net (decrease) increase in cash and cash equivalents (85) (285)
Cash and cash equivalents at beginning of period 1,825 2,061
Cash and cash equivalents at end of period 1,740 1,776
Eliminations [Member]
   
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 0 0
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash (used in) provided by operating activities 0 0
Cash flows from investing activities:    
Cost of business acquisitions, net of cash acquired   0
Capital expenditures 0 0
Purchase of investment 0 0
Proceeds from insurance claim   0
Proceeds from sale of property, plant and equipment 0 0
Net cash used in investing activities of continuing operations 0 0
Net cash provided by (used in) investing activities of discontinued operations 0 0
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 6.000% senior secured priority notes due 2019 0  
Proceeds from issuance of 8.500% junior secured priority notes due 2022 0  
Repayment of 7.875% senior subordinated notes   0
Repayment of Term Loan B due 2016   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Repayments of other long-term debt 0 0
Purchase and retirement of common stock upon vesting of RSUs 0 0
Repayments under Revolving Credit Facility, net   0
Proceeds from issuance of 15% Unsecured Term Loan due 2017   0
Repayment of 15% Unsecured Term Loan due 2017 0 0
Proceeds from issuance of Term Loan Facility due 2017   0
Repayment of Term Loan Facility due 2017 0  
Repayment of 8.875% senior second lien notes due 2018 0  
Borrowings under ABL Facility due 2017 0 0
Repayments under ABL Facility due 2017 0 0
Intercompany advances 0 0
Net cash provided by financing activities 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Net (decrease) increase in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0